On June 3, Stifel Nicolaus analyst Stephen Willey maintained a Buy rating on Nurix Therapeutics, Inc. (NASDAQ:NRIX) with a price target of $35. The reiteration comes after Sanofi exercised its ...

On May 29, 2025, Stifel analysts reiterated their Buy rating and $550 price target for Synopsys, Inc. (NASDAQ:SNPS) shares. The analysts said their decision is supported by their analysis of the ...

Analysts at Stifel are bullish about Illumina, Inc.’s (NASDAQ:ILMN) prospects despite the stock capitulating 36% year to date. On May 28, the analysts reiterated a Buy rating on the stock and a ...

Atlas Energy Solutions (NYSE:AESI) -2.5% in Wednesday's trading despite winning a Buy rating in initial coverage at Stifel, believing the Dune Express conveyor delivery system is "a truly ...

Stifel is asking a court to toss out a nearly $133 million arbitration penalty, alleging that one of the arbitrators was biased by previous work on a related case. In a petition filed on Friday ...

Stifel Nicolaus boosted their price target on shares of ZoomInfo Technologies from $13.00 to $14.00 and gave the stock a “buy” rating in a research note on Wednesday, February 26th.

Investors traded Stifel down by almost 4% in reaction, on a day when the S&P 500 index posted a nearly 2% improvement. For the quarter, Stifel's net revenue came in at just under $1.26 billion ...

Finally, Stifel Nicolaus lifted their target price on ZoomInfo Technologies from $13.00 to $14.00 and gave the company a “buy” rating in a research note on Wednesday, February 26th.

Roper Technologies (NASDAQ:ROP) late Wednesday was rated Buy in new research coverage by analysts at financial-services firm Stifel ... as reasons for the rating. Positioned as a diversified ...

Stifel Nicolaus analyst Annabel Samimy maintained a Buy rating on Rani Therapeutics Holdings (RANI – Research Report) today and set a price target of $8.00. The company’s shares closed ...